Advertisement
UK markets close in 1 hour 4 minutes
  • FTSE 100

    7,972.70
    +40.72 (+0.51%)
     
  • FTSE 250

    19,890.07
    +79.41 (+0.40%)
     
  • AIM

    743.64
    +1.53 (+0.21%)
     
  • GBP/EUR

    1.1698
    +0.0029 (+0.25%)
     
  • GBP/USD

    1.2635
    -0.0003 (-0.02%)
     
  • Bitcoin GBP

    56,455.23
    +1,570.28 (+2.86%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.81
    +6.32 (+0.12%)
     
  • DOW

    39,762.40
    +2.32 (+0.01%)
     
  • CRUDE OIL

    82.54
    +1.19 (+1.46%)
     
  • GOLD FUTURES

    2,234.20
    +21.50 (+0.97%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,506.93
    +29.84 (+0.16%)
     
  • CAC 40

    8,218.18
    +13.37 (+0.16%)
     

Company News For Oct 28, 2019

  • Amazon.com, Inc.’s AMZN shares slid 1.1% after the company reported third-quarter 2019 earnings of $4.23 per share, missing the Zacks Consensus Estimate by 23 cents

  • Shares of DMC Global Inc. BOOM jumped 18.7% after the company reported third-quarter 2019 earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.80

  • Shares of ResMed Inc. RMD rose 12.9% after the company reported third-quarter 2019 earnings of 93 cents, beating the Zacks Consensus Estimate by 6.9%

  • Melinta Therapeutics, Inc.’s MLNT shares dropped 23.3% after the company announced that there will be delay in launch of Baxdela due to liquidity issue, despite FDA’s approval


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
 
ResMed Inc. (RMD) : Free Stock Analysis Report
 
DMC Global Inc. (BOOM) : Free Stock Analysis Report
 
Melinta Therapeutics, Inc. (MLNT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research